Bone Marrow Transplant for Pediatric Medulloblastoma at Sheba Hospital- JCI accreditated and Top-10 Hospitals 2025 by Newsweek

• Consultation with an oncologist
• Bone marrow transplantation
• 3 meals per day by nutritionist
• 24-hr nurse services
• Electrocardiogram (ECG)
• Blood tests
• Chest X-ray
• Anti-HIV test
• Anti-HBC test
• Anti-HCVAb test
• Echocardiography
• Complete blood count (CBC)
• Biochemistry blood test
• PET/CT
• Consultation with an oncologist
• Consultation with a hematologist
• Consultation with an immunologist
• Consultation with a cardiologist
• Consultation with a pediatric hematologist
• Consultation with a pediatrician
• Сonsultation with an oncohematologist
• Head MRI
• Biopsy
• Computerized Bone Mineralometry (CBM)
• Complete blood count with cancer markers and a proteinogram

• 30 days in the hospital

• Transfer airport-clinic-airport

Bone Marrow Transplant for Pediatric Medulloblastoma

Sheba Medical Center – Advanced, Personalized Transplant Care for Children

At Sheba Medical Center, we understand how difficult it is for families to face a diagnosis of medulloblastoma. As the most common malignant brain tumor in children, it requires highly specialized and carefully coordinated care.

Today, one of the most important advances in treating medulloblastoma, especially in very young children, is the use of high-dose chemotherapy with stem cell support, also known as bone marrow transplantation (BMT).

At Sheba, this approach is a key part of modern treatment strategies designed not only to fight the tumor effectively, but also to protect the developing brain and support long-term quality of life.

The Role of Bone Marrow Transplant in Medulloblastoma

In pediatric medulloblastoma, BMT - more precisely called High-Dose Chemotherapy with Autologous Stem Cell Rescue (HDC-ASCR) - is a well-established and widely used treatment approach.

It plays a central role in:

Protecting the Developing Brain

In infants and very young children, this approach allows doctors to delay or avoid radiation therapy, helping preserve brain development and cognitive function while still delivering effective treatment.

Treating High-Risk Disease

In older children with higher-risk or more advanced disease, BMT is used as a consolidation phase following surgery and initial chemotherapy helping eliminate remaining cancer cells and strengthen treatment outcomes.

How the Treatment Works

Autologous Transplant (Child’s Own Cells)

This is the standard and most commonly used approach in medulloblastoma.

Stem cells are collected from the child in advance
High-dose chemotherapy is administered
The child’s own stem cells are reinfused to restore bone marrow and support recovery
Tandem (Multiple) Transplants

Many advanced protocols include two or more sequential transplant cycles.

This approach:

Increases treatment intensity in a controlled way
Enhances the ability to target remaining cancer cells
Is tailored individually to each child

Donor Options - Always a Solution Available

While most children with medulloblastoma are treated using their own stem cells, Sheba Medical Center also offers allogeneic (donor) transplantation when clinically appropriate.

If a donor-based approach is needed, our team ensures that every child has access to a suitable donor:

Matched sibling donors, when available
Matched unrelated donors through international registries
Haploidentical (half-matched) family donors, often a parent

With advanced matching technologies and global donor access, a suitable option can be identified even when a family match is not available.

Advanced Treatment Protocols

At Sheba Medical Center, treatment follows the most advanced international standards in pediatric neuro-oncology.

High-dose chemotherapy regimens may include:

Thiotepa – effective in reaching the brain
Carboplatin
Etoposide

Each treatment plan is carefully tailored to maximize effectiveness while supporting safety and recovery.

Precision, Safety, and Support

Children undergoing transplantation are treated in dedicated pediatric transplant units designed for both safety and comfort:

Child-friendly, highly protected environments
Advanced infection prevention systems
Continuous care by experienced pediatric specialists
Integrated Pediatric Neuro-Oncology Care

Care at Sheba is highly coordinated and personalized:

Integration of neurosurgery, chemotherapy, and transplant strategies
Access to advanced and targeted therapies
Close collaboration between neuro-oncologists, neurosurgeons, and transplant teams
Comprehensive supportive care throughout treatment
Clinical Expertise

Sheba Medical Center is a leading center for pediatric oncology and transplantation, offering:

Extensive experience in medulloblastoma and complex brain tumors
Expertise in HDC-ASCR and tandem transplant protocols
Outcomes aligned with leading international centers
Long-term follow-up focused on development and quality of life
Care That Supports the Whole Family

We understand that this journey affects the entire family.

At Sheba, families are supported by a multidisciplinary team including physicians, nurses, psychologists, and care coordinators ensuring guidance, reassurance, and continuous support at every stage.

Why Families Choose Sheba for Pediatric BMT

Leading pediatric transplant and neuro-oncology center
Expertise in advanced medulloblastoma treatment
Experience with radiation-sparing protocols
Ability to secure optimal donors when needed
Personalized, child-centered care
Dedicated international patient services

A Message of Hope

At Sheba Medical Center, we combine advanced science with compassionate pediatric care. Through innovative approaches like high-dose chemotherapy with stem cell support, we aim not only to treat medulloblastoma effectively, but also to protect each child’s future supporting families with confidence, care, and hope every step of the way.

• Personal medical coordinator
• Medical travel arrangements — booking of air tickets and hotel rooms at special partner prices
• Patient advocacy during medical travel